Class information for:
Level 1: ADAMS SUPER BRAIN STUDIES//LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS//ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
25090 243 44.8 85%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1849 5591 FETAL ALCOHOL SYNDROME//PRENATAL ALCOHOL EXPOSURE//FETAL ALCOHOL SPECTRUM DISORDERS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ADAMS SUPER BRAIN STUDIES Address 38 89% 7% 17
2 LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS Address 32 85% 7% 17
3 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN Author keyword 32 88% 6% 15
4 SECT DEV MOL PHARMACOL Address 18 47% 12% 28
5 ADNP Author keyword 17 70% 6% 14
6 DAVUNETIDE Author keyword 15 82% 4% 9
7 NAP DAVUNETIDE Author keyword 12 86% 2% 6
8 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN ADNP Author keyword 11 67% 4% 10
9 DR DIANA ZELMAN ELTON ELBAUM MOL NEUROENDOC Address 9 83% 2% 5
10 ELTON NEUROENDOCRINOL Address 9 83% 2% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN 32 88% 6% 15 Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN
2 ADNP 17 70% 6% 14 Search ADNP Search ADNP
3 DAVUNETIDE 15 82% 4% 9 Search DAVUNETIDE Search DAVUNETIDE
4 NAP DAVUNETIDE 12 86% 2% 6 Search NAP+DAVUNETIDE Search NAP+DAVUNETIDE
5 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN ADNP 11 67% 4% 10 Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN+ADNP Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN+ADNP
6 NAP 5 15% 13% 32 Search NAP Search NAP
7 ACTIVITY DEPENDENT NEUROTROPHIC FACTOR 5 50% 3% 7 Search ACTIVITY+DEPENDENT+NEUROTROPHIC+FACTOR Search ACTIVITY+DEPENDENT+NEUROTROPHIC+FACTOR
8 ADNF 9 4 67% 2% 4 Search ADNF+9 Search ADNF+9
9 STOP KO MICE 3 100% 1% 3 Search STOP+KO+MICE Search STOP+KO+MICE
10 MAP6 2 67% 1% 2 Search MAP6 Search MAP6

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 REDUCES TAU HYPERPHOSPHORYLATION 42 94% 6% 15
2 DEPENDENT NEUROPROTECTIVE PROTEIN 37 62% 16% 38
3 ADNP 24 91% 4% 10
4 ACTING NEUROPROTECTIVE PEPTIDE 21 85% 5% 11
5 DEPENDENT NEUROTROPHIC FACTOR 20 45% 14% 34
6 FEMTOMOLAR ACTING PEPTIDES 17 70% 6% 14
7 NEUROPROTECTIVE PEPTIDE 16 53% 9% 21
8 DAVUNETIDE 12 86% 2% 6
9 NEUROPROTECTIVE PROTEIN ADNP 12 86% 2% 6
10 PROTEIN ADNP 11 100% 2% 6

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide) 2011 11 52 85%
NAP (Davunetide) Provides Functional and Structural Neuroprotection 2011 10 55 85%
Activity-dependent neuroprotective protein: From gene to drug candidate 2007 41 58 55%
Protection Against Tauopathy by the Drug Candidates NAP (Davunetide) and D-SAL: Biochemical, Cellular and Behavioral Aspects 2011 7 72 69%
NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis 2007 29 60 47%
Microtubules, schizophrenia and cognitive behavior: Preclinical development of davunetide (NAP) as a peptide-drug candidate 2011 6 37 62%
D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy 2012 6 36 53%
Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein 2006 19 104 34%
Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets 2015 1 154 6%
PURIFICATION AND ASSAY OF COLD-STABLE MICROTUBULES AND STOP PROTEIN 1986 8 7 86%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ADAMS SUPER BRAIN STUDIES 38 89% 7.0% 17
2 LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS 32 85% 7.0% 17
3 SECT DEV MOL PHARMACOL 18 47% 12% 28
4 DR DIANA ZELMAN ELTON ELBAUM MOL NEUROENDOC 9 83% 2.1% 5
5 ELTON NEUROENDOCRINOL 9 83% 2.1% 5
6 CYTOSQUELETTE 7 39% 5.8% 14
7 U366 6 39% 4.9% 12
8 SEC DEV MOL PHARMACOL 4 75% 1.2% 3
9 GRP PHYSIOPATHOL CYTOSQUELETTE 3 50% 2.1% 5
10 SACKLER MEDADAMS SUPER BRAIN STUDIES 3 100% 1.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000290544 HUMANIN//COLIVELIN//S14G HUMANIN
2 0.0000163041 PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE PACAP
3 0.0000098704 TUBULIN ISOTYPES//TYROSINATION//DETYROSINATION
4 0.0000090405 KOVALESKII BIOL SO SEAS//VARIABLE FACTORS//OBESITY MARKERS
5 0.0000087976 MICROTUBULE ASSOCIATED PROTEIN 1B//MAP1B//MAP1A
6 0.0000081027 FETAL ALCOHOL SYNDROME//PRENATAL ETHANOL EXPOSURE//PRENATAL ETHANOL
7 0.0000074612 ARGINYLATION//JOHANSON BLIZZARD SYNDROME//N END RULE
8 0.0000072449 GRP BIOPHYSSTAT//PROTEIN MICROTUBULES//TUBULIN RINGS
9 0.0000061250 DISC1//DYSBINDIN//NEUREGULIN 1
10 0.0000060906 TAU//PAIRED HELICAL FILAMENTS//TAU PROTEIN